期刊文献+

3例儿童Bartter综合征生长发育和实验室指标随访 被引量:1

下载PDF
导出
摘要 目的分析治疗后Bartter综合征儿童生长发育的特点、实验室指标变化和不良反应情况。方法 3例Bartter综合征患儿规律治疗2年,观察其身高、体重、生长速度、实验室检查指标和不良反应等。结果儿童Bartter综合征在经积极治疗后身高和体重增加明显,在骨龄增长正常情况下生长追赶,血胰岛素样生长因子-1水平升高,且患儿电解质、血气分析、24 h尿钙、肾功能、尿常规等基本正常,泌尿系超声未见钙化,而肾素和醛固酮经治疗后在病例3仍略高于正常,在病例1和2中恢复正常。治疗过程中未见明显不良反应。结论 Bartter综合征经积极治疗可明显改善患儿的身高和体重,预后较好。
出处 《广东医学》 CAS CSCD 北大核心 2014年第9期1368-1370,共3页 Guangdong Medical Journal
基金 江西省卫生厅科技计划项目(编号:20131053)
  • 相关文献

参考文献10

  • 1AKIL I, OZEN S, KANDILOGLU A R, et al. A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis[ J ]. Clin Exp Nephrol, 2010, 14(3) : 278 -282.
  • 2李辉.中国0-18岁儿童青少年生长图表[M].上海第二军医大学出版社,2009.21-25.
  • 3BARTFER F C, PRONOVE P, GILL J R Jr, et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome[J]. Am J Med, 1962, 33 : 811 - 828.
  • 4SUZUKIM, MORITA T, IWAMOTO T. Diversity of Cl - Channels [J]. Cell Moe Life Sci, 2006, 63(1) : 12 -24.
  • 5AMIRLAK I, DAWSON K P. Bartter syndrome: an overview[J]. QJM, 2000, 93(4) : 207 -215.
  • 6NAESENSA M, STEELSB P, VERBERCKMOESA R, et al. Barter's and Gitelman's syndromes: from gene to clinic[ J]. Nephron Physiol, 2004, 96(3): 65-78.
  • 7PURICELLI E, BETTINELL A, BORSA N, et al. Long - term follow - up of patients with Bartter syndrome type I and II [ J ]. Nephrol Dial Transplant, 2010, 25:2976-2981.
  • 8VAISBICH M H, FUJIMURA M D, KOCH V H. Bartter syndrome:benefits and side effects of long -term treatment [ J ]. Pediatr Nephrol, 2004, 19(8) : 858 -863.
  • 9邵加庆,赵明,田成功.巴特综合征研究进展[J].医学研究生学报,2007,20(8):853-856. 被引量:11
  • 10BHAT Y R, VINAYAKA G, SREELAKSHMI K. Antenatal bartter syndrome:a review[J]. Int J Pediatr, 2012, 2012:857136 - 857141.

二级参考文献21

  • 1邵加庆,田成功.低钾麻痹诊治的研究进展[J].医学研究生学报,2005,18(3):255-257. 被引量:8
  • 2Starremans PG,Kersten FF,Knoers NV.Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters[J].J Am Soc Nephrol,2003,14(6):1419-1426.
  • 3Cho JT,Guay-Woodford LM.Heterozygous mutations of the gene for Kir 1.1 (ROMK) in antenatal Bartter syndrome presenting with transient hyperkalemia,evolving to a benign course[J].J Korean Med Sci,2003,18(1):65-68.
  • 4Guay-Woodford L.Bartter syndrome:unraveling the pathophysiologic enigma[J].Am J Med,1998,105(2):151-161.
  • 5Hayama A,Rai T,Sasaki S,et al.Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene[J].Histochem Cell Biol,2003,119(6):485-493.
  • 6Miyamura N,Matsumoto K,Taguchi T,et al.Atypical Bartter syndrome with sensorineural deafness with G47R mutation of the beta-subunit for ClC-Ka and ClC-Kb chloride channels,barttin[J].J Clin Endocrinol Metab,2003,88(2):781-786.
  • 7Hebert SC.Bartter syndrome[J].Curr Opin Nephrol Hypertens,2003,12(5):527-532.
  • 8Shaer AJ.Inherited primary renal tubular hypokalemic alkalosis:a review of Gitelman and Bartter syndromes[J].Am J Med Sci,2001,322(6):316-332.
  • 9Amirlak I,Dawson KP.Bartter syndrome:an overview[J].QJM,2000,93(4):207-215.
  • 10Singh PJ,Nash JL,Santella RN,et al.Gitelman's syndrome:report of a 19-year old woman with intractable hypomagnesemia and hypokalemia,and a review of the syndrome[J].S D J Med,1999,52(10):377-380.

共引文献13

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部